JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. (2021)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-1807
PubMed Identifier: 33822745
Publication URI: http://europepmc.org/abstract/MED/33822745
Type: Journal Article/Review
Volume: 81
Parent Publication: Cancer research
Issue: 4
ISSN: 0008-5472